Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Macromolecular Drugs Bioanalysis

Macromolecular Drugs Bioanalysis

Our Bioanalysis Department can provide analysis of macromolecular drugs in accordance with FDA and NMPA GLP standards to support the selection and development, of small molecule drugs, antibody drugs, vaccines and biomarkers.
Download
Medicilon icon-diamond.pngService
  • Development and methodological verification of macromolecular bioanalysis methods
    Develop, transfer, optimize and verify immunoassay methods for the determination of drug concentration in a biological matrixDevelop and optimize immunoassay methods for drugs such as adalimumab, bevacizumab, trastuzumab, pertuzumab and antibody drug conjugateQuickly and efficiently complete methodological verification to support the needs of potential projects
  • Analysis of proteins, antibodies, polypeptides and drugs
    Global clinical and preclinical trialsPharmacokinetics, toxicity and immunogenicity testsBioequivalence experiments
  • Biological markers
    Inflammation markersOrthotopic markersMetabolic disease markersCardiovascular disease markersBone markers
  • Vaccine analysis
    Detection of monovalent and multivalent vaccinesDetection of multi-serotype antibodiesHigh-throughput automation technology
  • Immunogenicity tests
    Selection testsDeterministic testsTiter determination
Medicilon icon-diamond.pngFeature Platform
  • Nucleic Acid Drugs Bioanalysis
    PK/TK AnalysisImmunogenicity analysisPD or TOX-related cytokines and biomarkers (Cytokine & Biomarker)
  • Metabolite Identification
    In vitro incubation metabolite identificationReactive metabolite identificationIn vivo metabolite identification
  • ADC Immunogenicity
    Immunogenicity is a key parameter when evaluating biologic therapeutics. It could increase the potential risk of adverse effects and reduced ADC efficacy. Medicilon fully understands the complexity of ADA evaluation and offers our clients with comprehensive immunogenicity assays.
Medicilon icon-diamond.pngHighlights
  • Comprehensive information management, a perfect sample management chain and experimental data processing, tracking and storage chain by using the verified laboratory information management system (Watson LIMS 7.2);Verified WinNonlin software for data analysis;Data accepted by FDA and NMPA, and biotechnology drug analysis services that fully meet FDA/NMPA/OECD GLP requirements;Independent micromolecule bioanalysis platform and bio-tech-based drug analysis platform;All-round and multifunctional technology platforms including SpectraMaxM4/M5/i3x, MSD, Luminex, Biacore 8K, Envision, Gyrolab and ABI7500 qPCR;Flexible employment of ELISA, ECL, IP, Co-IP, qPCR, FACS, Elspot, enzymology and other methods to support the early development, preclinical and clinical assessment of biopharmaceuticals, including proteins, antibodies (monoclonal antibodies, bi- or multi-specific antibodies and antibody fragments), ADCs, polypeptides, nucleic acids, vaccines and cell gene therapy drugs. Development and verification of analytical methods for diverse targets such as CD-4, CTI-4, PD-1, PD-L1 and T-DM1 analog ADC to support the analysis of PK/TK/Total ADA (NAB)/biomarker/cytokine.
Medicilon icon-diamond.pngStrength
  • Development of immunoassay and verification of methodologyAnalysis of protein, antibody, ADC, polypeptide drugs, vaccines and cell and gene therapy productsSelection and analysis of biomarkers and detection of cytokinesImmunogenicity test of anti-drug antibody (ADA)Determination of vaccinesBiological analysis of clinical samplesSupport for pharmacokinetics (PK), toxicokinetics (TK), tissue distribution test and IND filings
Medicilon icon-diamond.pngInstruments
  • MSD Sector Imager 6000/SQ120Molecule Devices M4/M5e/i3X Plate ReaderBioTek ELx405 Plate WasherGyrolab xPloreCytoFlex FACSCTL ELISPOTQIAcuity One 5 Plex ddPCRNanodrop NP-80Vi-CELL XR cell CounterPE Envision plate readerLuminexBiacore 8KABI7500 qPCR
FAQ
  • Advantages and Disadvantages of Ligand Binding Assay

    LBA:Main Advantages 

      Sensitivity: High 

      Quantitation: Cost effective and Fast

    LBA:Main Disadvantage 

      Require good reagent (time) 

      Dilutions, nonlinear, matrix effect, hook effect, etc.

Relevant laboratories
  • Gyrolab-xPlore
  • MSD
  • RAD
  • Bio-Plex-200
  • PCR
  • BioTek-ELx405-Select-Plate-washer
  • uv
  • Multifunctional microplate reader
  • Biacore
Relevant articles